Vimta Labs — 360° view

Vimta Labs, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹112 crore and net profit of ₹21 crore for the September 2026 quarter.

Vimta Labs (NSE: VIMTALABS) closed at ₹467.65 on 20 Nov 2026, down 24.6% over the past year. Its market capitalisation is ₹2,090 crore and it trades at 25.7 times earnings.

Share price
₹467.65 (20 Nov 2026)
Market cap
₹2,090 Cr (20 Nov 2026)
P/E
25.66 (20 Nov 2026)
Revenue
₹112 Cr (September 2026 quarter)
Net profit
₹21 Cr (September 2026 quarter)
ROCE
25.2% (FY26)
ROE
18.9% (FY26)
Book value
₹110 (FY26)
Dividend yield
0.43% (last 12 months to 20 Nov 2026)
52-week high / low
₹675.00 / ₹376.05 (20 Nov 2026)
1-year return
-24.6% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Research, Analytics & Technology
Symbol
NSE: VIMTALABS

Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.